May 4, 2018 / 12:50 PM / 19 days ago

BRIEF-Glenmark Pharma Says Co Suspended Trial Conducted at Malpani Hospital After Alleged Irregularities

May 4 (Reuters) - Glenmark Pharmaceuticals Ltd:

* CLARIFIES ON NEWS ITEM ABOUT CO GETTING NOTICE OVER MISCONDUCT IN CLINICAL TRIALS

* GLENMARK PHARMACEUTICALS - AS SOON AS CO BECAME AWARE OF ALLEGED IRREGULARITIES AT MALPANI HOSPITAL, TRIAL WAS SUSPENDED

* SAYS CO GOT SHOW CAUSE NOTICE PERTAINING TO MONITORING OF CLINICAL TRIAL AT MALPANI HOSPITAL

* GLENMARK PHARMACEUTICALS - DEVELOPMENT DOES NOT HAVE MATERIAL IMPACT ON CO Source text - bit.ly/2rkAUzw Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below